Free Trial

NeuroOne Medical Technologies Q2 2023 Earnings Report

NeuroOne Medical Technologies logo
$0.86 -0.01 (-1.13%)
As of 04:00 PM Eastern

NeuroOne Medical Technologies EPS Results

Actual EPS
-$0.21
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NeuroOne Medical Technologies Revenue Results

Actual Revenue
$0.47 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NeuroOne Medical Technologies Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Remove Ads

NeuroOne Medical Technologies Earnings Headlines

“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…
See More NeuroOne Medical Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NeuroOne Medical Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeuroOne Medical Technologies and other key companies, straight to your email.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies (NASDAQ:NMTC), a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

View NeuroOne Medical Technologies Profile

More Earnings Resources from MarketBeat